Abstract
AbstractSodium imaging (23Na-MRI) is of interest in neurological conditions given potential sensitivity to the physiological and metabolic status of tissues. Benchmarks have so far been restricted to parenchyma or grey/white matter (GM/WM). We investigate (1) the availability of evidence, (2) regional pooled estimates and (3) variability attributable to regional/methodology.MEDLINE literature search for Tissue sodium concentration (TSC) measured in specified ‘healthy’ brain regions returned 127 reports plus 278 retrieved from bibliographies. 28 studies met inclusion criteria, including 400 individuals. Reporting variability led to nested data structure, so we used multilevel meta-analysis and a random effects model to pool effect sizes.The pooled mean from 141 TSC estimates was 40.51 mM (95% CI: 37.59 - 43.44; p< 0.001, I2Total=99.4%). Tissue as a moderator was significant (F214=65.34, p-val < .01). Six sub-regional pooled means with requisite statistical power were derived. We were unable to consider most methodological and demographic factors sought because of non-reporting, but each factor included beyond tissue improved model fit. Significant residual heterogeneity remained.The current estimates provide an empirical point of departure for better understanding in23Na-MRI. Improving on current estimates supports: (1) larger, more representative data collection/sharing, including (2) regional data, and (3) agreement on full reporting standards.
Publisher
Cold Spring Harbor Laboratory